Neurodegeneration and Neuroprotection in Parkinson Disease
Summary: Many of the motoric features that define Parkinson disease (PD) result primarily from the loss of the neuromelanin (NM)-containing dopamine (DA) neurons of the substantia nigra (SN), and to a lesser extent, other mostly catecholaminergic neurons, and are associated with cytoplasmic “Lewy bo...
Збережено в:
| Опубліковано в:: | NeuroRx |
|---|---|
| Автори: | , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Am. Soc. for Experimental NeuroTherapeutics
2004
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC534919/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15717014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1602/neurorx.1.1.139 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|